Table 5.
Results of univariate regression analyses for the association between the convalescent plasma infusion and secondary outcomes.
| Variables | Effect Estimate (95%CI) | p-Value # |
|---|---|---|
| Clinical status at day 14 | OR: 1.50 (0.76–2.98) | 0.244 1 |
| Clinical status at day 28 | OR: 0.77 (0.31–1.88) | 0.565 1 |
| Clinical status at end of follow-up | OR: 0.33 (0.08–1.33) | 0.119 1 |
| Hospital discharge | OR: 2.93 (0.74–11.64) | 0.127 2 |
| Time to hospital discharge | HR: 0.68 (0.46–0.99) | 0.05 3 |
| Intubation | OR: 2.37 (0.93–6.01) | 0.072 2 |
| Time to intubation | HR: 0.48 (0.19–1.21) | 0.122 3 |
| Extubation | OR: 30.3 (2.64–348.9) | 0.006 2 |
| Time to extubation | HR: 0.68 (0.08–5.44) | 0.712 3 |
| Exit from ICU | OR: 15.16 (2.02–113.3) | 0.008 2 |
| Time to exit from ICU | HR: 0.54 (0.07–4.41) | 0.566 3 |
| Achievement of PCR negativity | OR: 1.84 (0.78–4.36) | 0.168 2 |
| Time to reach PCR negativity | HR: 0.74 (0.42–1.29) | 0.741 3 |
# Highlighted (bold) p-values denote statistically significant results 1 Ordinal logistic regression analysis; 2 binary logistic regression analysis; 3 cox proportional hazard regression analysis.